Drug details

Thyquidity (levothyroxine sodium oral solution)

type of Thyroid Products

Thyquidity (levothyroxine sodium) is levothyroxine sodium (T4) indicated as replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism; and as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.

This drug may have the following side effects:
  • diarrhea,
  • shortness of breath,
  • weight loss,
  • headache,
  • nervousness,
  • muscle weakness,
  • insomnia,
  • irritability,
  • muscle spasm,
  • tremors,
  • skin rash
  • increased appetite,
  • heart attack,
  • irregular heartbeats (arrhythmias),
  • heat intolerance,
  • menstrual irregularities, and
The following drugs are related to Thyquidity, either as a replacement or used together:
  • Cytomel (liothyronine sodium)
  • Levothroid (levothyroxine sodium)
  • Levoxyl (levothyroxine sodium)
  • Unithroid (levothyroxine sodium)
  • Synthroid (levothyroxine sodium)
  • Tirosint (levothyroxine sodium capsules)
  • Tirosint-Sol (levothyroxine sodium oral solution)
  • Triostat (liothyronine sodium injection)
  • Thyrolar (liotrix)
  • Nature-Throid (thyroid tablets)